We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
신규 편입 · 포트폴리오 비중 0.00%
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $28.55 · 11 analysts
Stored first · Google News · Yahoo Finance (English)
Docebo's (DCBO) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Docebo's (DCBO) Buy Rating Reiterated at Needham & Company LLC MarketBeat
Docebo Announces up to $70 Million Substantial Issuer Bid, Reports Preliminary Q2 Results
Docebo (NASDAQ:DCBO) Shares Gap Up - Should You Buy? - MarketBeat
Docebo (NASDAQ:DCBO) Shares Gap Up - Should You Buy? MarketBeat
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Movin - Benzinga
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Movin Benzinga
Sector Update: Tech Stocks Fall Pre-Bell Friday
Docebo Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2026 and Fiscal Year Ending December 31, 2026 - marketscreener.com
Docebo Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2026 and Fiscal Year Ending December 31, 2026 marketscreener.com
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 07. | After market close (AMC) | $0.31 | — | — | $66.86M | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 22. | Cantor Fitzgerald | — | Maintain | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 04. 22. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2026. 03. 03. | Scotiabank | — | Maintain | Sector Outperform → Sector Outperform | — | Scotiabank: Sector Outperform |
| 2026. 03. 03. | Morgan Stanley | — | Maintain | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2026. 02. 28. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2026. 01. 31. | Scotiabank | — | Maintain | Sector Outperform → Sector Outperform | — | Scotiabank: Sector Outperform |
Price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 273,932 | $4.79M | 0.00% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 118,077 | $2.62M | 0.00% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 41,482 | $921.24K | 0.00% | — | New position |
| 4 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 14,283 | $249.84K | 0.00% | — | New position |